The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 22, 2019

Filed:

Aug. 28, 2017
Applicant:

Yale University, New Haven, CT (US);

Inventors:

Tarek M. Fahmy, New Haven, CT (US);

Alan Dardik, Bethany, CT (US);

Assignee:

YALE UNIVERSITY, New Haven, CT (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/28 (2006.01); A61L 27/00 (2006.01); A61L 27/36 (2006.01); A61L 27/24 (2006.01); A61L 27/26 (2006.01); A61L 27/30 (2006.01); A61L 27/34 (2006.01); A61L 27/54 (2006.01); A61K 31/436 (2006.01); A61K 31/4439 (2006.01);
U.S. Cl.
CPC ...
A61L 27/3641 (2013.01); A61K 31/436 (2013.01); A61K 31/4439 (2013.01); A61L 27/24 (2013.01); A61L 27/26 (2013.01); A61L 27/306 (2013.01); A61L 27/34 (2013.01); A61L 27/3604 (2013.01); A61L 27/3633 (2013.01); A61L 27/3687 (2013.01); A61L 27/54 (2013.01); A61L 2300/62 (2013.01); A61L 2400/12 (2013.01); A61L 2400/18 (2013.01); A61L 2420/06 (2013.01);
Abstract

Composite prosthetic patches with covalently bound particles for controlled drug release, and methods of making and using thereof, have been developed. The particles may encapsulate one or more therapeutic, prophylactic or diagnostic agent(s). Generally, the prosthetic patches are decellularized extracellular matrix such as bovine or porcine pericardium or synthetic polymeric materials. The size of the particles ranges from between 1 nm and 1000 μm, preferably from between 10 nm and 500 nm. In some embodiments, the agent is a therapeutic agent for treatment of neointimal hyperplasia. In other embodiments, the agent is a therapeutic agent for suppressing or resolving inflammation. In yet other embodiments, the agent is a therapeutic for mitigating scarring.


Find Patent Forward Citations

Loading…